Local News: Ashburn, VA 

 | 

Sign Up

 | 

Sign In

Kyphon Newswire

Comprehensive Real-Time News Feed for Kyphon.

Results 1 - 20 of 333 in Kyphon

  1. Maintaining CitizenshipRead the original story

    13 hrs ago | The Daily News

    For the fifth straight year, Memphis-based Medtronic Spine employees are spending the month of June volunteering at more than a dozen locations in the area.

    Comment?

  2. Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone...Read the original story w/Photo

    Yesterday | PRWeb

    Yale University researchers this week released the findings of two independent studies of Medtronic's Infuse bone graft products.

    Comment?

  3. Medtronic slips after Infuse reviews detailed Shares of Medtronic...Read the original story

    Yesterday | Vallejo News

    Shares of Medtronic Inc. slipped Tuesday, a day after the medical device maker announced findings from independent reviews of studies of its Infuse bone graft THE SPARK: The Minneapolis company said the reviews, conducted through Yale University, concluded that clinical success rates with its Infuse product were equivalent to more traditional bone ... (more)

    Comment?

  4. Medtronic's Infuse No Better Than Bone Graft With More RiskRead the original story

    Tuesday | The Washington Post

    Medtronic Inc.'s Infuse, designed to help bones heal after spinal surgery, works no better than a graft and carries side effects including an increased risk of cancer, two independent reviews found.

    Comment?

  5. Medtronic Slips After Infuse Reviews DetailedRead the original story

    Tuesday | The Daily News

    Shares of Medtronic Inc . slipped Tuesday, a day after the medical device maker announced findings from independent reviews of studies of its Infuse bone graft THE SPARK: The Minneapolis company with a presence in Memphis said the reviews, conducted through Yale University, concluded that clinical success rates with its Infuse product were ... (more)

    Comment?

  6. First-of-Its-Kind Independent Review of INFUSE Bone Graft Coordinated by Yale University is CompleteRead the original story

    Tuesday | Bioscience Technology

    June 17, 2013 - Medtronic, Inc. [NYSE: MDT] acknowledged today the publication of the findings from Yale University's third-party, independent review of INFUSEA Bone Graft, a proprietary formulation of recombinant human bone morphogenetic protein-2 that was approved by the U.S. Food and Drug Administration in 2002 for use in anterior lumbar ... (more)

    Comment?

  7. Focus On MedtronicRead the original story

    Tuesday | Seeking Alpha

    One of my recent purchases for my Covestor Healthcare Model is Medtronic, Inc. .

    Comment?

  8. The Changing Structure of Industry-Sponsored Clinical Research:...Read the original story

    Monday Jun 17 | Annals of Internal Medicine

    Disclaimer: The author is an employee of Medtronic and serves as a member of the Board of Governors for the Patient Centered Outcomes Research Institute.

    Comment?

  9. Medtronic's Infuse No Better Than Bone Graft With More Risk, Study FindsRead the original story

    Monday Jun 17 | Bloomberg

    Medtronic Inc. 's Infuse, designed to help bones heal after spinal surgery, works no better than a graft and carries side effects including an increased risk of cancer, two independent reviews found.

    Comment?

  10. First-of-Its-Kind Independent Review of INFUSEA Bone Graft...Read the original story

    Monday Jun 17 | PR-inside.com

    INFUSE Bone Graft Remains Important Treatment Option MINNEAPOLIS - June 17, 2013 - Medtronic, Inc. [NYSE: MDT] acknowledged today the publication of the findings from Yale University's third-party, independent review of INFUSE Bone Graft, a proprietary formulation of recombinant human bone morphogenetic protein-2 that was approved by the U.S. Food ... (more)

    Comment?

  11. Medtronic Aortic Valves Don't Infringe Edwards German PatentRead the original story

    Friday Jun 14 | The Washington Post

    Medtronic Inc.'s aortic valve, inserted into the heart via a catheter, doesn't violate Edwards Lifesciences Inc.'s Cribier patent, the German District Court of Mannheim ruled.

    Comment?

  12. Medtronic Aortic Valves Don't Infringe Edwards Patent in GermanyRead the original story

    Friday Jun 14 | The Washington Post

    Medtronic Inc.'s aortic valve, inserted into the heart via a catheter, doesn't violate Edwards Lifesciences Inc.'s Cribier patent, the German District Court of Mannheim ruled.

    Comment?

  13. Medtronic Unveils Baseline Data Of Extreme Risk Patients Enrolled In CoreValveA U.S. Pivotal TrialRead the original story

    Friday Jun 14 | PR-inside.com

    Study Presents Comprehensive Dataset of Patient Characteristics Collected on Extreme Risk TAVR Patients VANCOUVER - June 14, 2013 - Medtronic, Inc. today presented baseline characteristics of patients enrolled in the Extreme Risk Study of the Medtronic CoreValve U.S. Pivotal Trial at the Transcatheter Valve Therapies conference.

    Comment?

  14. Facebook Inc (FB), Edwards Lifesciences Corp (EW): Reasons to Buy These Three StocksRead the original story w/Photo

    Thursday Jun 13 | Insider Monkey

    It has been a tough year for Edwards Lifesciences Corp . The stock has declined 24% in 2013 alone due to disappointing sales.

    Comment?

  15. Medtronic Stock Sees Short Interest Decline 18%Read the original story w/Photo

    Thursday Jun 13 | Forbes.com

    The most recent short interest data has been released by the NASDAQ for the 05/31/2013 settlement date, which shows a 2,351,638 share decrease in total short interest for Medtronic short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it ... (more)

    Comment?

  16. FDA to medical-device makers: Prepare for hackersRead the original story

    Thursday Jun 13 | Business Journal

    The Food and Drug Administration wants med-tech companies such as Medtronic to ensure their devices can withstand cybersecurity threats.

    Comment?

  17. Medtronic Announces CE Mark of ReDuX Plier InstrumentRead the original story

    Thursday Jun 13 | Benzinga

    Medtronic, Inc. announced today the CE Mark and the European launch of the ReDuX Plier, a new instrument specially designed for use during osteotomies.

    Comment?

  18. Medtronic Announces CE Mark of Its ReDuX(TM) Plier Instrument, an...Read the original story

    Wednesday Jun 12 | PR-inside.com

    Novel Disruptive Instrument for Controlled and Progressive Restoration of the Sagittal Imbalance in Patient with Spinal Deformity NICE, France - June 13, 2013 - Medtronic, Inc. announced today the CE Mark and the European launch of the ReDuX Plier, a new instrument specially designed for use during osteotomies.

    Comment?

  19. Providence Medical names vice president of salesRead the original story

    Wednesday Jun 12 | Customer Interaction Solutions

    ... president, sales for S-I BONE, Inc. Kevin worked closely with Providence's management in integrating St. Francis with Kyphon, and later with Medtronic, following its purchase of Kyphon. "I'm excited for Kevin to lead our US product launches and grow ...

    Comment?

  20. Edwards Lifesciences Corp (EW): Is This Fallen Angel Still a Good Growth Play?Read the original story w/Photo

    Tuesday Jun 11 | Insider Monkey

    Healthcare stocks resemble tech stocks, in that both are eye candy to growth investors, show volatility over business cycles and thus have less appeal to value investors.

    Comment?